Skip to content

Clinical trials

Phase 2/3 Colitis, Ulcerative trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colitis, Ulcerative Phase: Phase 2/3 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20062
20072
20131
20151
20161
20182
20193
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated8
Completed6
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Facet Biotech3
Janssen Research & Development, LLC3
AbbVie2
Theravance Biopharma2
Boehringer Ingelheim1
Bristol-Myers Squibb1
Dartmouth-Hitchcock Medical Center1
Gilead Sciences1
Incara Pharmaceuticals1
Stanford University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative16
Inflammatory Bowel Diseases2
Colitis1
Colonic Diseases1
Digestive System Diseases1
Gastrointestinal Diseases1
Intestinal Diseases1
Pouchitis1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.